Cannabis
Cosma Launches New Medical Cannabis Strains in Collaboration with Cannprisma – Gorilla Girl and Blue Monkey
Cosma partnered with Cannprisma to introduce two exclusive medical cannabis strains—Gorilla Girl (sativa-dominant) and Blue Monkey (indica-dominant)—to support mental health, pain, and sleep issues. This collaboration ensures local production and supply continuity, offering Polish patients high-quality cannabis. Cosma aims to expand strain options, addressing diverse patient needs.
Cosma is introducing two new varieties of medical cannabis to the domestic market – Gorilla Girl and Blue Monkey. Thanks to the cooperation with the Portuguese company Cannprisma, Polish patients will gain access to new varieties of medical cannabis. Here’s what you should know about this initiative and what benefits it will bring to patients.
Cosma and Cannprisma cooperation – the first project of this kind on the Polish market
Cosma SA , known for its efforts to develop the medical cannabis market in Poland, has entered into a strategic partnership with Cannprisma Enhanced Medical Cannabis based in Portugal. The aim of this cooperation is not only to introduce new varieties, but also to ensure stable supplies of pharmaceutical raw materials for the domestic market.
As part of the agreement, Cosma has obtained exclusive rights to distribute new cannabis strains – Gorilla Girl and Blue Monkey – in Poland. This project is unique because it is the first such broad initiative aimed at supporting local patients by providing products that are available exclusively for the Polish market.
New Medical Cannabis Strains: Gorilla Girl and Blue Monkey
Gorilla Girl – Sativa Dominant
Gorilla Girl is a sativa -dominant strain , meaning it has the potential to support patients in their struggles with mental health issues such as depression, anxiety, and lack of energy. The genetics of this strain are based on a combination of Gorilla Glue and Girl Scout Cookies , two well-known strains that are known for their high THC content and unique terpene profile.
THC content : 20%
CBD content : ≤1%
Potential Medical Uses : Gorilla Girl can help improve mood, increase energy, and support focus. With its sativa dominance, it is suitable for those who need extra motivation and mental support.
Blue Monkey – Indica dominant
The second strain introduced by Cosma is Blue Monkey – a strain with a predominance of indica genes . This is a great option for patients who need support in the fight against pain, insomnia or muscle tension. Blue Monkey is a cross between Gorilla Glue and Black Blueberry , which combines relaxing properties, making it especially appreciated by patients with sleep problems.
THC content : 21%
CBD content : ≤1%
Potential Medical Applications : Blue Monkey supports relaxation and calm, making it an ideal evening choice for patients with sleep problems and chronic pain.
The Importance of Local Production and Distribution of Medical Cannabis
Cosma is the first company on the Polish market to ensure that the cultivation of these varieties is intended exclusively for domestic needs, which contributes to shorter delivery times, better quality control and continuity of supplies.
In order for the project to be implemented in accordance with Polish regulations, Cosma had to complete many formalities, such as registering the products with the Office for Registration of Medicinal Products, Medical Devices and Biocidal Preparations. Thanks to this, Polish patients can be sure that these products meet the highest safety and quality standards.
Challenges and the future of medical cannabis distribution in Poland
The distribution of medical cannabis in Poland faces a number of challenges, mainly related to legal regulations and the need to adapt to control requirements. Cosma, through its cooperation with Cannprisma, aims to meet these challenges and provide products that meet strict pharmaceutical standards.
In the future, Cosma plans to introduce more varieties of medical cannabis that will be able to better meet the diverse needs of patients. It is also worth emphasizing that the success of this project may be an impulse for other companies to get involved in local initiatives, which will have a positive impact on the development of the market.
The introduction of new medical cannabis varieties by Cosma in cooperation with Cannprisma is a breakthrough for the Polish market. Thanks to local production and exclusive distribution for patients in Poland, Cosma offers products that can significantly improve the quality of life of people using medical cannabis. Gorilla Girl and Blue Monkey are already available in Poland, which provides patients not only with a wider choice, but also with certainty about the quality and origin of the products.
__
(Featured image by Esteban Lopez via Unsplash)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in FaktyKonopne. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us
-
Biotech1 week ago
Bayer Reduces Losses in the First Nine Months and Sales Fall by 2.5%
-
Fintech14 hours ago
Money Walkie Completes its Fourth Fundraising with a Crowdfunding Campaign on Sowefund
-
Crypto2 weeks ago
Bitcoin Hits New All-Time High – Donald Trump and US Election Drive Up Price
-
Biotech6 days ago
Grifols Is Closer to a Takeover Bid: Brookfield Raises 11 Billion Euros